Efficiency in Extracorporeal Membrane Oxygenation—Cellular Deposits on Polymethypentene Membranes Increase Resistance to Blood Flow and Reduce Gas Exchange Capacity
- 1 November 2008
- journal article
- respiratory support
- Published by Ovid Technologies (Wolters Kluwer Health) in ASAIO Journal
- Vol. 54 (6), 612-617
- https://doi.org/10.1097/mat.0b013e318186a807
Abstract
Bioline-coated polymethylpentene (PMP) membrane oxygenators (MO) are used for extracorporeal membrane oxygenation (ECMO) to improve gas exchange in patients with severe acute respiratory distress syndrome (ARDS). However, in some patients, long-term durability is limited due to fibrous and cellular accumulations on the gas exchange surface which can increase resistance to blood flow and diffusion path. These surface deposits of PMP MO after removal were studied with scanning electron and fluorescence microscopy techniques. Three of 31 patients supported by a PMP MO in an ECMO setting required a replacement of the oxygenator after a mean support interval of 11 ± 7 days due to an increase in flow resistance and an impairment of the gas exchange capacity. The membrane surface of the MO was covered with a fibrous network with imbedded platelets and red blood cells. A membranous structure composed of single cells and clusters of cells covered large areas of the PMP fibers. We assume that these cellular deposits lower the efficacy of ECMO. The identification of these cells could be a key for future therapeutic interventions and improvements in the development of MO.Keywords
This publication has 24 references indexed in Scilit:
- Duration of Red-Cell Storage and Complications after Cardiac SurgeryThe New England Journal of Medicine, 2008
- Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: Clinical experiences in 45 adult patientsThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Accumulation of fibronectin in the heart after myocardial infarction: a putative stimulator of adhesion and proliferation of adipose-derived stem cellsCell and tissue research, 2008
- Elimination of sevoflurane is reduced in plasma-tight compared to conventional membrane oxygenatorsEuropean Journal of Anaesthesiology, 2008
- Up to 151 days of continuous animal perfusion with trivial heparin infusion by the application of a long-term durable antithrombogenic coating to a combination of a seal-less centrifugal pump and a diffusion membrane oxygenatorJournal of Artificial Organs, 2007
- The history of extracorporeal oxygenators*Anaesthesia, 2006
- A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia*Critical Care Medicine, 2006
- Four Years’ Experience With a Miniaturized Extracorporeal Circulation System and Its Influence on Clinical OutcomeArtificial Organs, 2004
- The Effects of Heparin Coating of Oxygenator Fibers on Platelet Adhesion and Protein AdsorptionAnesthesia & Analgesia, 1999
- Coagulopathic-induced membrane dysfunction during extracorporeal membrane oxygenation: a case reportPerfusion, 1997